6RK73
CAS No. 1895050-66-4
6RK73 ( —— )
产品货号. M26038 CAS No. 1895050-66-4
6RK73 is a covalent irreversible and specific UCHL1 inhibitor (IC50: 0.23 μM).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2535 | 有现货 |
|
10MG | ¥4350 | 有现货 |
|
25MG | ¥7039 | 有现货 |
|
50MG | ¥9639 | 有现货 |
|
100MG | ¥12879 | 有现货 |
|
500MG | ¥26082 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称6RK73
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述6RK73 is a covalent irreversible and specific UCHL1 inhibitor (IC50: 0.23 μM).
-
产品描述6RK73 is a covalent irreversible and specific UCHL1 inhibitor (IC50: 0.23 μM). 6RK73 shows almost no inhibition of UCHL3 (IC50: 236 μM).(In Vitro):6RK73 (5 μM; 1-3 hours) treatment displays strong inhibition of the TGFβ-induced pSMAD2 and pSMAD3, and a decrease of TβRI and total SMAD protein levels in MDA-MB-436 cells. 6RK73 (5 μM; 24-48 hours) results in migration significantly slower than the DMSO control group in MDA-MB-436 cells.(In Vivo):6RK73 displays a potent inhibition of breast cancer extravasation in zebrafish.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Antioxidant
-
研究领域——
-
适应症——
化学信息
-
CAS Number1895050-66-4
-
分子量307.4
-
分子式C13H17N5O2S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(Nc1ncc(s1)N1CCOCC1)[C@H]1CCN(C1)C#N
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Safranal Attenuates Excitotoxin-Induced Oxidative OLN-93 Cells Injury
产品手册
关联产品
-
Gap19 TFA (1507930-5...
Gap19 TFA is a peptide derived from nine amino acids of Cx43 cytoplasmic ring (CL), an effective, selective connexin 43 (Cx43) half-channel blocker.
-
N-(2-{bis[2-(2,2-dic...
N-(2-{bis[2-(2,2-dichloroacetamido)ethyl]amino}ethyl)-2,2-dichloroacetamide hydrochloride is a chemical compound.
-
Cajanin
Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.